![](img/space.gif) |
Factors influencing the expression of plasmid-mediated quinolone determinants (PMQRs)
|
Help
Print
|
Here you can view and search the projects funded by NKFI since 2004
Back »![](img/space.gif)
![](img/space.gif)
![](img/space.gif)
![](img/space.gif)
|
![](img/print_ver.gif) |
List of publications |
|
|
Domokos J, Damjanova E, Kristóf K, Kocsis B, Szabo D: Multiple benefits of plasmid-mediated quinolone resistance determinants in Klebsiella pneumoniae ST11 high-risk clone and recently emerging ST307 clone., Front Microbiol. 2019 Feb 12;10:157. doi: 10.3389/fmicb.2019.00157. eCollection 2019., 2019 | Kocsis B, Toth A, Gulyas D, Ligeti B, Katalin K, Rokusz L, Szabo D.: Acquired qnrVC1 and blaNDM-1 in international high-risk Pseudomonas aeruginosa ST773 clone, J. Med. Microbiol: 2019 Mar;68(3):336-338., 2019 | Szabó O, Gulyás D, Szabó N, Kristóf K, Kocsis B, Szabó D.: Plasmid-mediated quinolone resistance determinants in Enterobacteriaceae from urine clinical samples., Acta Microbiol Immunol Hung. 2018 Aug 1;65(3):255-265. doi: 10.1556/030.65.2018.012. Epub 2018 Feb 23., 2018 | Szabo O, Kocsis B, Szabo N, Kristof K, Szabo D.: Contribution of OqxAB Efflux Pump in Selection of Fluoroquinolone-Resistant Klebsiella pneumoniae., Can J Infect Dis Med Microbiol. 2018 Sep 23;2018:4271638. doi: 10.1155/2018/4271638. eCollection 2018., 2018 | Gulyás D, Kocsis B, Szabó D.: Plasmid copy number and qnr gene expression in selection of fluoroquinolone-resistant Escherichia coli., Acta Microbiol Immunol Hung. 22:1-10. doi: 10.1556/030.65.2018.049. [Epub ahead of print], 2018 | Kocsis B, Szmolka A, Szabo O, Gulyas D, Kristóf K, Göcző I, Szabo D.: Ciprofloxacin Promoted qnrD Expression and Phylogenetic Analysis of qnrD Harboring Plasmids, Microb Drug Resist. 2018 Nov 21. doi: 10.1089/mdr.2018.0245. [Epub ahead of print], 2018 | Kocsis B, Szabo D.: New treatment options for lower respiratory tract infections., Expert Opin Pharmacother. 2017 Sep;18(13):1345-1355. doi: 10.1080/14656566.2017.1363179. Epub 2017 Aug 8., 2017 | Sebe I, Kállai-Szabó B, Zelkó R, Szabó D: Polymers and Formulation Strategies of Nanofibrous Systems for Drug Delivery Application and Tissue Engineering, CURR MED CHEM 22: (5) 604-617, 2015 | Sebe I, Ostorhazi E, Fekete A, Kovacs NK, Zelko R, Kovalszky I, Li W, Wade JD, Szabo D, Otvos L Jr: Polyvinyl alcohol nanofiber formulation of the designer antimicrobial peptide APO sterilizes Acinetobacter baumannii‑infected skin wounds in mice, Amino Acids 48(1):203-11., 2016 | Domokos J, Szabo D, Kristof K: Detection of plasmid-mediated quinolone resistance determinants in extended-spectrum beta-lactamse producing Enterobactericeae strains, Acta Microbiologica et Immunologica Hungarica 2016 Sep;63(3):313-323., 2016 | Kocsis B, Kádár B, Tóth Á, Fullár A, Szabó D.: MgrB variants in colistin-susceptible and colistin-resistant Klebsiella pneumoniae ST258., J Microbiol Immunol Infect. 2016 Jul 29. pii: S1684-1182(16)30071-8., 2016 | Kocsis B, Domokos J, Szabo D.: Chemical structure and pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacin., Ann Clin Microbiol Antimicrob. 23;15(1):34., 2016 | Domokos J, Szabo D, Kristof K: Detection of plasmid-mediated quinolone resistance determinants in extended-spectrum beta-lactamse producing Enterobactericeae strains, Acta Microbiologica et Immunologica Hungarica 2016 Sep;63(3):313-323., 2016 | Kadar B, Kocsis B, Toth A, Kristof K, Felso P, Kocsis B, Boddi K, Szabo D: Colistin resistance associated with outer membrane protein change in Klebsiella pneumoniae and Enterobacter asburiae, ACTA MICROBIOL IMMUNOL HUNG 64: (2) 217-227, 2017 | Kocsis B, Kádár B, Tóth Á, Fullár A, Szabó D: MgrB variants in colistin-susceptible and colistin-resistant Klebsiella pneumoniae ST258, J MICROBIOL IMMUNOL 50: (5) 735-736, 2017 | Kocsis B, Szabo D: New treatment options for lower respiratory tract infections., EXPERT OPIN PHARMACO 18: (13) 1345-1355, 2017 | Ivady B, Kenesei E, Toth-Heyn P, Kertesz G, Tarkanyi K, Kassa C, Ujhelyi E, Mikos B, Sapi E, Varga-Heier K, Guoth G, Szabo D: Factors influencing antimicrobial resistance and outcome of Gram-negative bloodstream infections in children, INFECTION 44: (3) 309-321, 2016 | Kocsis B, Szabo D: Zabofloxacin for chronic bronchitis., DRUGS TODAY 52: (9) 495-500, 2016 | Ivady B, Szabo D, Damjanova I, Pataki M, Szabo M, Kenesei E: Recurrent outbreaks of Serratia marcescens among neonates and infants at a pediatric department: an outbreak analysis., INFECTION 42: (5) 891-898, 2014 | Juhasz J, Kertesz-Farkas A, Szabo D, Pongor S: Emergence of Collective Territorial Defense in Bacterial Communities: Horizontal Gene Transfer Can Stabilize Microbiomes., PLoS One. 2014 Apr 22;9(4):e95511, 2014 | Ivady B; Szabo D; Damjanova I; Pataki M; Szabo M; Kenesei E: Recurrent outbreaks of Serratia marcescens among neonates and infants at a pediatric department: an outbreak analysis., Infection PMID: 25015432, 2014 | Sebe I, Kállai-Szabó B, Zelkó R, Szabó D: Polymers and Formulation Strategies of Nanofibrous Systems for Drug Delivery Application and Tissue Engineering, CURR MED CHEM 22: (5) 604-617, 2015 | Sebe I, Ostorhazi E, Fekete A, Kovacs NK, Zelko R, Kovalszky I, Li W, Wade JD, Szabo D, Otvos L Jr: Polyvinyl alcohol nanofiber formulation of the designer antimicrobial peptide APO sterilizes Acinetobacter baumannii‑infected skin wounds in mice, AMINO ACIDS In press: In press, 2015 | Domokos J, Szabo D, Kocsis B, Kristof K: Detection of plasmid-mediated quinolone resistance determinants in extended-spectrum beta-lactamse producing Enterobactericeae strains, Acta Microbiologica et Immunologica Hungarica, 2015 |
![](img/space.gif)
|
|
|
![](img/shadow_right_up.gif)
|
![](img/shadow_left_bottom.gif)
|
![](img/shadow_right_bottom.gif)
|
![](img/space.gif)
Back »
|
![](img/space.gif) |
|